Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Drug delivery
Reexamination Certificate
2001-01-30
2004-06-22
Lucchesi, Nicholas D. (Department: 3764)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Drug delivery
C623S001100, C623S001440, C606S108000
Reexamination Certificate
active
06752829
ABSTRACT:
FIELD OF THE INVENTION
This invention relates generally to an implantable medical device for delivering biologically active materials. More specifically, the invention relates to an implantable stent prosthesis for delivering a biologically active material and a method for manufacturing the same. More particularly, the invention is directed to a stent having one or more channels for containing and delivering a biologically active material.
BACKGROUND OF THE INVENTION
Balloon angioplasty has been very effective in treating stenosis, i.e., to open blocked vessels and restore normal levels of blood flow. However, although once a blocked vessel is opened, the treated vessel has a tendency to restenose, i.e., reclose, shortly after the procedure. Thus, patients have to repeatedly be treated with angioplasty or surgery.
Implantable stent prosthesis or stents are used to reduce restenosis after balloon angioplasty or other procedures using catheters. A stent in the form of a wire mesh tube props open an artery that has recently been cleared using angioplasty. The stent is collapsed to a small diameter, placed over an angioplasty balloon catheter and moved into the area of the blockage. When the balloon is inflated, the stent expands, locks in place and forms a scaffold to hold the artery open. Usually, the stent stays in the artery permanently, holds it open, improves blood flow to the heart muscle and relieves symptoms. The stent procedure is fairly common, and various types of stents have been developed and actually used.
However, the metal surfaces of stents currently in use may trigger restenosis. To prevent the stented arteries from reclosing, patients who receive stents must take one or more anticoagulating drugs, such as heparin, aspirin, coumadin, dextran, and/or persantine even though systemic application of anticoagulants has been known to cause bleeding complications.
To reduce the likelihood of restenosis caused by the metal surface of such stents, stents covered with polymers and a drug have been offered. However, those covered stents are still not completely satisfactory. Therefore, there is a need for additional devices or methods to reduce the necessity for systemic application of anticoagulants and alleviate restenosis.
Further, for certain diseases which are localized to a particular part of body, the systemic administration of a biologically active material for the treatment of these diseases may not be preferred because of the inefficiencies associated with the indirect delivery of the biologically active material to the afflicted area. Therefore, there is a need for a device or method to deliver the biologically active material directly to a particular part of the body.
SUMMARY OF THE INVENTION
These and other objects are accomplished by the present invention. To achieve the aforementioned objectives, we have invented an implantable stent prosthesis with channels and methods for manufacturing the same.
The implantable stent prosthesis of the present invention comprises a sidewall and at least one channel for containing a biologically active material, wherein the sidewall comprises at least in part a plurality of struts having an exterior surface.
The present invention also includes a method for making such implantable stent prosthesis. In an embodiment, at least one tube or mandrel is placed in contact with a covering material on a stent. The tube or mandrel is surrounded by the covering material, and then a channel is formed so that it is located within the covering material and wherein the channel has two open ends.
In another embodiment, a tube or mandrel is covered with a channel material. The covered tube or mandrel is exposed to either heat treatment, chemical treatment or treatment with an adhesive, to form a channel having two open ends. The channel is attached to a sidewall of a stent.
Further, in another embodiment, a tube or mandrel is covered with a channel material. The covered tube or mandrel is exposed to either heat treatment, chemical treatment or treatment with an adhesive, to form a channel having two open ends. The channel is attached to a strut material to form a stent wire. The stent wire is woven to form the sidewall of the stent.
The present invention also includes a method of treating an afflicted area of a surface of a body lumen by implanting the stent prosthesis containing a biologically active material. The biologically active material is delivered to the afflicted area.
REFERENCES:
patent: 4655771 (1987-04-01), Wallsten
patent: 4733665 (1988-03-01), Palmaz
patent: 4800882 (1989-01-01), Gianturco
patent: 4886062 (1989-12-01), Wiktor
patent: 4954126 (1990-09-01), Wallsten
patent: 5061275 (1991-10-01), Wallsten et al.
patent: 5098381 (1992-03-01), Schneider
patent: 5254089 (1993-10-01), Wang
patent: 5389314 (1995-02-01), Wang
patent: 5409012 (1995-04-01), Sahatjian
patent: 5411550 (1995-05-01), Herweck et al.
patent: 5486191 (1996-01-01), Pasricha et al.
patent: 5603694 (1997-02-01), Brown et al.
patent: 5735892 (1998-04-01), Myers et al.
patent: 5755722 (1998-05-01), Barry et al.
patent: 5769883 (1998-06-01), Buscemi et al.
patent: 5810767 (1998-09-01), Klein
patent: 5824046 (1998-10-01), Smith et al.
patent: 5843033 (1998-12-01), Ropiak
patent: 5843172 (1998-12-01), Yan
patent: 5857998 (1999-01-01), Barry
patent: 5891108 (1999-04-01), Leone et al.
patent: 5928247 (1999-07-01), Barry et al.
patent: 5954693 (1999-09-01), Barry
patent: 5981568 (1999-11-01), Kunz et al.
patent: 5997468 (1999-12-01), Wolff et al.
patent: 6071305 (2000-06-01), Brown et al.
patent: 6124523 (2000-09-01), Banas et al.
patent: 6379382 (2002-04-01), Yang
patent: 2001/0010012 (2001-07-01), Edwin et al.
patent: WO 99/17682 (1999-04-01), None
patent: WO 01/67991 (2001-09-01), None
patent: WO 01/87372 (2001-11-01), None
International Search Report as to PCT/US02/02635 which claims priority based on U.S. patent application 09/774,218.
Girton Timothy Samuel
Kocur Gordon John
Hamilton Lalita M.
Lucchesi Nicholas D.
Pennie & Edmonds LLP
Sci-Med Life Systems, Inc.
LandOfFree
Stent with channel(s) for containing and delivering a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stent with channel(s) for containing and delivering a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stent with channel(s) for containing and delivering a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3304708